Zyla Life Sciences Deferred Tax Assets, Other
Zyla Life Sciences had Deferred Tax Assets, Other of $152.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOther · last filed 2019-03-29
- 2018-12-31: Deferred Tax Assets, Other $152.00K.
- 2017-12-31: Deferred Tax Assets, Other $341.00K.
- 2016-12-31: Deferred Tax Assets, Other $366.00K.
- 2015-12-31: Deferred Tax Assets, Other $2.00K.
| Period end | Deferred Tax Assets, Other |
|---|---|
| 2018-12-31 | $152.00K 10-K · filed 2019-03-29 |
| 2017-12-31 | $341.00K 10-K · filed 2019-03-29 |
| 2016-12-31 | $366.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | $2.00K 10-K · filed 2017-03-13 |